Pfizer COVID-19 vaccine partially protecting towards Omicron – Bloomberg Information

The Omicron variant of the coronavirus can partially evade the safety from Pfizer Inc and accomplice BioNTech’s COVID-19 vaccine, Bloomberg Information reported on Tuesday, citing the analysis head of a laboratory at Africa Well being Analysis Institute in South Africa.

Its evasion just isn’t full and a booster shot might present extra safety, in accordance with the report, citing Alex Sigal, head of the lab.

The Omicron variant, first detected in southern Africa final month, has triggered alarms globally of one other surge in infections, with greater than two dozen nations from Japan to the USA reporting circumstances.

The World Well being Group on Nov. 26 labeled it as a “variant of concern”, however stated there was no proof to assist the necessity for brand new vaccines particularly designed to sort out the Omicron variant with its many mutations.

Sigal didn’t instantly reply to a Reuters request for remark.

See also  Keto weight-reduction plan could assist you to battle the flu